Andrew J Bradley

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. pmc A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism
    H Y Chan
    Department of General Psychiatry, Taoyuan Mental Hospital, Taoyuan, Taiwan
    J Psychopharmacol 24:91-8. 2010
  2. doi request reprint Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
    Andrew J Bradley
    Eli Lilly and Co Ltd, Basingstoke, UK
    J Psychopharmacol 27:740-58. 2013
  3. doi request reprint A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality
    Andrew J Bradley
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 24:91-118. 2010
  4. doi request reprint Schizophrenia and breast cancer incidence: a systematic review of clinical studies
    Chris J Bushe
    Eli Lilly and Company Ltd, Lilly House, Priestly Road, Basingstoke RG24 9NL, UK
    Schizophr Res 114:6-16. 2009

Collaborators

Detail Information

Publications4

  1. pmc A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism
    H Y Chan
    Department of General Psychiatry, Taoyuan Mental Hospital, Taoyuan, Taiwan
    J Psychopharmacol 24:91-8. 2010
    ..Double-blinded, fixed dose and different ethnical study for EPS-intolerant schizophrenic patients is needed to confirm the results of our study...
  2. doi request reprint Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
    Andrew J Bradley
    Eli Lilly and Co Ltd, Basingstoke, UK
    J Psychopharmacol 27:740-58. 2013
    ....
  3. doi request reprint A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality
    Andrew J Bradley
    Eli Lilly and Company Ltd, Basingstoke, UK
    J Psychopharmacol 24:91-118. 2010
    ..It is likely that this contributes to the pattern of poor physical health and premature mortality suffered by people with schizophrenia, in particular the high rates of cardiovascular and metabolic disturbance...
  4. doi request reprint Schizophrenia and breast cancer incidence: a systematic review of clinical studies
    Chris J Bushe
    Eli Lilly and Company Ltd, Lilly House, Priestly Road, Basingstoke RG24 9NL, UK
    Schizophr Res 114:6-16. 2009
    ..We undertook a systematic review of published data to investigate possible reasons for the variable findings...